Deborah Quinn

2017

In 2017, Deborah Quinn earned a total compensation of $423.5K as Chief Medical Officer at Bellerophon Therapeutics, a 7% decrease compared to previous year.

Compensation breakdown

Bonus$120,000
Salary$303,461
Total$423,461

Quinn received $303.5K in salary, accounting for 72% of the total pay in 2017.

Quinn also received $120K in bonus.

Rankings

In 2017, Deborah Quinn's compensation ranked 12,430th out of 14,666 executives tracked by ExecPay. In other words, Quinn earned more than 15.2% of executives.

ClassificationRankingPercentile
All
12,430
out of 14,666
15th
Division
Manufacturing
4,888
out of 5,768
15th
Major group
Chemicals And Allied Products
1,789
out of 2,074
14th
Industry group
Drugs
1,487
out of 1,730
14th
Industry
Pharmaceutical Preparations
1,149
out of 1,329
14th
Source: SEC filing on April 5, 2018.

Quinn's colleagues

We found two more compensation records of executives who worked with Deborah Quinn at Bellerophon Therapeutics in 2017.

2017

Fabian Tenenbaum

Bellerophon Therapeutics

Chief Executive Officer

2017

Peter Fernandes

Bellerophon Therapeutics

Chief Regulatory and Safety Officer

You may also like